[PLX] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -26.23%
YoY- -114.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 12,247 2,006 6,358 1,769 4,616 2,686 3,064 25.96%
PBT -7,743 -11,294 450 -10,736 -5,071 -6,119 -6,837 2.09%
Tax 3 75 3,045 213 43 202 0 -
NP -7,743 -11,294 450 -10,853 -5,071 -6,119 -6,837 2.09%
Tax Rate - - -676.67% - - - - -
Total Cost 19,990 13,300 5,908 12,622 9,687 8,805 9,901 12.41%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -63.22 -563.01 7.08 -613.51 -109.86 -227.81 -223.14 -18.94%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.52 -0.77 0.04 -0.11 -0.05 -0.07 -0.07 39.66%
EPS Diluted -0.52 -0.77 -0.60 -0.11 -0.05 -0.07 -0.07 39.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.